Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Nicholas John Sedgwick CEO | LSE Exchange | GB0031030819 ISIN |
United Kingdom Country | 290 Employees | - Last Dividend | - Last Split | - IPO Date |